Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.
Focus of the Report: This Health Technology Assessment focuses on percutaneous pulmonary valve implantation (PPVI) with Edwards Sapien 3 or Sapien XT valves for the treatment of right ventricular outflow tract (RVOT) defects.
Technology Description: The goal of PPVI is to improve hemodynamics, cardiopulmonary function, and survival while delaying the n…
Focus of the Report: This Health Technology Assessment (HTA) focuses on the use of the Micra transcatheter pacing system (TPS) (Medtronic Inc.) as a leadless alternative to traditional transvenous pacemakers (TVPMs) for the management of patients with bradycardia or atrioventricular (AV) block in the presence or absence of atrial fibrillation…
Focus of the Report: This Health Technology Assessment focuses on the use of functional electrical stimulation (FES) for treatment of foot drop in patients who have a history of stroke an average of ≥ 1 year prior to FES treatment. This mean 1-year threshold was implemented to ensure that the majority of enrolled patients within each study we…
Focus of the Report: This Health Technology Assessment focuses on the use of functional electrical stimulation (FES) for treatment of foot drop in patients who have a history of stroke < 1 year prior to FES treatment. A mean 1-year threshold was implemented to ensure that the majority of enrolled patients within each study were was in the acu...
Focus of the Report: This report focuses on percutaneous peripheral nerve stimulation (PNS) therapy utilizing an external pulse generator for the treatment of adults with intractable chronic pain (pain persisting for ≥ 3 months).
Technology Description: Percutaneous PNS is a nonpharmac…
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the safety and effectiveness of fecal microbiota transplantation (FMT) to treat patients with Crohn disease (CD).
Technology Description: FMT is a procedure by which processed stool from healthy donors i…
Focus of the Report: The focus of this Health Technology Assessment is the use of phrenic nerve stimulation (PNS) with the remedē System for the treatment of central sleep apnea (CSA).
Technology Description: Phrenic nerve stimulation (PNS), also known as diaphragm pacing, is the elect…
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the safety and effectiveness of Impella devices for hemodynamic support during high-risk percutaneous coronary intervention (HRPCI).
Technology Description: The Impella 2.5, Impella CP (Cardiac Power), a…
Focus of the Report: This Health Technology Assessment focuses on the use of prescription digital therapeutics (PDTs) for the management of type 2 diabetes mellitus (T2DM) in adults.
Technology Description: PDTs are a mobile technology that offers patients with diabetes mellitus (DM) t…
Focus of the Report: This Health Technology Assessment focuses on the use of the Eversense Continuous Glucose Monitoring (CGM) System (Senseonics Inc.). This minimally invasive, implantable CGM device is used to continuously monitor interstitial glucose levels in patients with diabetes mellitus (DM), with the goal of improving glycemic control and long-term outcomes.